Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2407421 | Vaccine | 2008 | 8 Pages |
Abstract
SummaryPrevious studies have demonstrated that mice deficient in the macrophage migration inhibitory factor (MIF) gene are protected from ovariectomy (OVX)-induced bone loss. We developed a novel MIF-deoxyribonucleic acid (DNA) vaccine by introducing oligonucleotides encoding a helper T epitope into the cDNA sequence of murine MIF. Mice given the MIF-DNA vaccine produced high titers of autoantibody against MIF, and were protected from OVX-induced bone loss. Our results further support the hypothesis that MIF is involved in the pathomechanism of OVX-induced bone loss, and also show that active immunization against MIF using a DNA vaccine may be useful for the prophylactic treatment of postmenopausal osteoporosis.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Shin Onodera, Shigeki Oshima, Jun Nishihira, Kazunori Yasuda, Harukazu Tohyama, Kazuharu Irie, Yoshikazu Koyama,